Search

Author/Creator Anderson, D.J.

1. CB-5083, a first-in-class p97 inhibitor that disrupts protein homeostasis, exhibits anti-tumor activity in a panel of solid tumor xenografts. (December 2016)

Authors:
Lee, G.J.; Le Moigne, R.; Anderson, D.J.; Djakovic, S.; Menon, M.K.; Valle, E.; Wong, S.; Soriano, F.; Tang, Y.; Yao, B.; Zhou, H.J.; Rajangam, K.; Rolfe, M.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease. (April 2017)

Authors:
Ethun, C.G.; Lopez-Aguiar, A.G.; Anderson, D.J.; Adams, A.B.; Fields, R.C.; Doyle, M.B.; Chapman, W.C.; Krasnick, B.A.; Weber, S.M.; Mezrich, J.D.; Salem, A.; Pawlik, T.M.; Poultsides, G.; Tran, T.; Idrees, K.; Isom, C.A.; Martin, R.C.G.; Scoggins, C.R.; Shen, P.; Mogal, H.D.
Journal:
HPB
Issue:
Volume 19(2017)Supplement 1
Page Start:
S1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗